Alopecia Global Market Report 2024

“Alopecia Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on alopecia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for alopecia? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The alopecia market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Alopecia Areata; Androgenetic Alopecia; Alopecia Totalis; Traction Alopecia; Cicatricial Alopecia; Other Types
• 2) By Treatment: Pharmaceutical; Low Level Laser Therapy (LLLT) Devices; Hair Transplant; Regenerative Medicine; Other Treatments
• 3) By Gender: Male; Female
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• 5) By End-User: Dermatology Clinics; Homecare Settings; Other End-Users
• Companies Mentioned: Pfizer Inc.; Johnson and Johnson Ltd.; Merck and Co. Inc.; Bayer AG; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Alopecia is a medical term describing the loss of hair, which can occur naturally, be associated with illnesses or the use of specific medications. It can manifest as localized or diffuse, temporary or permanent, and affect individuals of all ages and both genders. Treatment for alopecia aims to slow down, reverse, or manage hair loss and encourage regrowth in affected areas.

The primary types of alopecia include alopecia areata, androgenetic alopecia, alopecia totalis, traction alopecia, cicatricial alopecia, and others. Alopecia areata is an autoimmune condition characterized by sudden hair loss resulting in circular or oval patches on the scalp or other body areas. Various treatment options encompass pharmaceuticals, low-level laser therapy devices, hair transplants, regenerative medicine, and more. These treatments are available through diverse distribution channels like hospital pharmacies, retail pharmacies, online pharmacies, and others, catering to a wide range of end-users including dermatology clinics, home care settings, and more.

The alopecia market research report is one of a series of new reports from The Business Research Company that provides alopecia market statistics, including alopecia industry global market size, regional shares, competitors with an alopecia market share, detailed alopecia market segments, market trends and opportunities and any further data you may need to thrive in the alopecia industry. This alopecia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The alopecia market size has grown strongly in recent years. It will grow from $5.28 billion in 2023 to $5.76 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to growing awareness of diagnosis, increasing consumer demand, increasing number of international medical tourism centers, improved reimbursement scenarios.

The alopecia market size is expected to see strong growth in the next few years. It will grow to $7.82 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing aging population, rising cosmetic concerns, increasing lifestyle factors, rising healthcare expenditure. Major trends in the forecast period include advancements in treatment options, biotechnological innovations, the growing use of artificial intelligence (AI) and machine learning (ML) in alopecia research.

The anticipated rise in the prevalence of hair loss is expected to drive the growth of the alopecia market in the coming years. Hair loss, characterized by the partial or complete loss of hair from its typical growth areas, is a condition that affects many individuals. Alopecia treatments play a crucial role in addressing various aspects of hair loss, including promoting hair regrowth, devising personalized treatment strategies, utilizing combination therapies, and managing the physical manifestations of hair loss. These interventions can significantly enhance an individual's emotional well-being and overall quality of life. For example, as of April 2023, data from the China-based National Health Commission indicates that over 250 million Chinese people have experienced hair loss, with 42% of them falling within the age range of 26 to 30. Additionally, data from the US-based Statistic Brain Research Institute in February 2023 reveals that approximately 40% of men will experience noticeable hair loss by the age of 35, and this percentage will increase to 65% by the age of 60. Hence, the growing prevalence of hair loss is a key driver behind the expansion of the alopecia market.

The substantial increase in government initiatives is poised to drive the growth of the alopecia market in the future. Government initiatives encompass specific actions, policies, programs, or projects undertaken by government authorities at various levels to address particular issues, achieve specific objectives, or enhance the overall well-being of their constituents and society as a whole. Government initiatives can significantly contribute to the advancement of alopecia treatment through various means, such as allocating funds for research, expediting the approval process for new drugs and therapies, and launching public awareness campaigns to educate both the public and healthcare professionals about alopecia. As an illustration, in June 2022, the Government of Ireland, as reported by gov.ie, introduced a new grant of $525.36 (€500) to assist individuals experiencing hair loss due to illness in covering the costs of wigs, hairpieces, or other hair replacements. Such initiatives can notably enhance the quality of life for those dealing with alopecia and related conditions. Consequently, the upsurge in government initiatives is a driving force behind the growth of the alopecia market.

The elevated expenses associated with treatment pose a challenge and have the potential to impede the market's growth throughout the forecast period. Alopecia treatment can be financially burdensome, encompassing costs for hair replacement products, medical consultations, and hospital procedures. This financial burden may significantly impact individuals dealing with alopecia. For example, in September 2022, Healthline, a US-based online health information platform, reported that the cost of topical alopecia treatments like minoxidil can range from $40 to $1,000. Hence, the high treatment costs are a restraining factor affecting the expansion of the alopecia market.

Major companies operating in the alopecia market are focused on developing an innovative treatments to gain competitive advantages in the market. For instance, in June 2022, Eli Lilly and Company, a US-based pharmaceutical company and Incyte, a US-based pharmaceutical company, unveiled their approval for is luminant oral tablets by the United States Food and Drug Administration (FDA), a US-based federal agency. It is the first FDA-approved systemic treatment for treating severe alopecia areata in adults. Olumiant is also indicated for treating adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more tumor necrosis factor (TNF) blockers.

In March 2023, Sun Pharmaceutical Industries Limited, an India-based pharmaceutical company, acquired Concert Pharmaceuticals for $576 million. With this acquisition, Sun Pharmaceutical aims to improve and enhance its alopecia treatment offerings and expand its product portfolio. Concert Pharmaceuticals Inc. is a US-based biopharmaceutical company involved in developing oral inhibitors of Janus kinases as a treatment for alopecia areata.

Major players in the alopecia market are Pfizer Inc., Johnson and Johnson Ltd., Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi SA, GlaxoSmithKline PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Allergan PLC, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Intertek Group PLC, Dr. Reddy's Laboratories Ltd., Cipla Limited, Almirall S.A., Aclaris Therapeutics Inc., Curallux LLC, Theradome Inc., Lexington International LLC, Histogen Inc., Apira Science Inc.

North America was the largest region in the alopecia market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the alopecia report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the alopecia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The alopecia market consists of revenues earned by entities by providing anagen effluvium, telogen effluvium, and alopecia universalis treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. The alopecia market also includes the sales of shampoos, drugs, and hair regrowth supplements. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.